Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis

Clinical and Experimental Immunology

Volumn 138, Issue 3, 2004, Pages 547-553

  Chauhan, S Kumar ^a   Tripathy, N Kumar ^a   Sinha, N ^a   Singh, M ^b   Nityanand, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

Author keywords

Autoimmunity; Human HSP60; Mycobacterial HSP65; Takayasu's arteritis

Indexed keywords

AZATHIOPRINE; BROXURIDINE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE;

ADOLESCENT; ADULT; AORTA ARCH SYNDROME; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFECTION; LYMPHOCYTIC INFILTRATION; MALE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIBODIES; ANTIBODY FORMATION; AUTOIMMUNITY; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CHAPERONIN 60; CHAPERONINS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TAKAYASU'S ARTERITIS;

EID: 9644282831     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02644.x     Document Type: Article

References (39)

1. Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am 1995; 21:1041-58.
2. Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F. Clinical manifestations of Takayasu arteritis in India and Japan: new classification of angiographic findings. Angiology 1997; 48:369-79.
3. Mohan N, Kerr G. Takayasu's Arteritis. Curr Treat Options Cardiovasc Medical 1999; 1:35-42.
4. Johnston SL, Lock RJ, Compels MM. Takayasu arteritis: a review. J CHn Pathol 2002; 55:481-6.
5. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol 1996; 54 (Suppl.):S111-6.
6. Murangan MN, Bavdekar SB, More V, Desmukh H, Tripathy M, Vaswani R. Study of Takayasu's arteritis in children: clinical profile and management. J Post Grad Med 2000; 46:3-8.
7. Brogan PA, Dillon MJ. Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2000; 2:411-6.
8. Nityanand S, Giscombe R, Srivastava S, Hjelmstrom P, Sanjeevi CB, Sinha N, Grunewald J, Lefvert AK. A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol 1997; 107:261-8.
9. Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R. Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis. Int J Cardiol 2000; 75 (Suppl. 1):S77-7.
10. Sima D, Thiele B, Turowski A, Wilke K, Hiepe F, Volk D, Sonnichsen N. Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum 1994; 37:441-3.
11. Nityanand S, Mishra K, Shrivastava S, Holm G, Lefvert AK. Autoantibodies against cardiolipin and endothelial cells in Takayasu's arteritis. prevalence and isotype distribution. Br J Rheumatol 1997; 36:923-4.
12. Baltazares M, Mendoza F, Dabague J, Reyes PA. Antiaorta antibodies and Takayasu arteritis. Int J Cardiol 1998; 66 (Suppl. 1):S183-7.
13. Tripathy NK, Sinha N, Nityanand S. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity. J Rheumatol 2003; 30:2023-6.
14. Morrison R, Milner LS, Jacobs D, Thompson PD, Kala U, Franklin J, Ninin D. The role of mycobacteria in Takayasu's arteritis (TA). Kidney Int 1989; 35:913.
15. Kothari SS. Aetiopathogenesis of Takayasu's arteritis and BCG vaccination: the missing link? Med Hypotheses 1995; 45:227-30.
16. Seko Y, Minota S, Kawasaki A et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest 1994; 93:750-8.
17. Hernandez-Pando R, Reyes P, Espitia C, Wang Y, Rook G, Mancilla R. Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis. J Rheumatol 1994; 21:1870-6.
18. Aggarwal A, Chag M, Sinha N, Naik S. Takayasu's arteritis. role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J Cardiol 1996; 55:49-55.
19. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for classification of Takayasu's arteritis. Arthritis Rheum 1990; 33:1129-34.
20. Sharma BK, Jain S, Ganguly NK. Intracellar signal transduction in T-cells in Takayasu's arteritis. Ann NY Acad Sci 1996; 793:453-5.
21. Noris M, Pharm DC, Diana E, Gamba S, Bonazzola S, Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis. A guide for therapeutic decisions? Circulation 1999; 100:55-60.
22. Moraes MF, Ordway D, Oliveira L, Costa IL, Badura R, Pinheiro MN, da Graca JM, Ventura FA. Cellular immune responses to Mycobacterium tuberculosis in a patient with Takayasu's arteritis. Rev Port Cardiol 1999; 18:359-67.
23. Sireci G, Dieli F, Salerno A. T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease. Mol Med 2000; 6:581-90.
24. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, Akoglu T. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet's disease. J Rheumatol 2000; 27:708-13.
25. Hasan A, Fortune F, Wilson A et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet 1996; 347:789-94.
26. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, Yamamoto S, Sakane T. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol 1997; 108:204-12.
27. Yokota S, Tsubaki K, Kuriyama T et al. Presence in Kawasaki disease of antibodies to mycobacterial heat shock protein HSP65 and autoantibodies to epitopes of human HSP65 cognate antigen. Clin Immunol Immunopathol 1993; 67:163-70.
28. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 2002; 22:1547-59.
29. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest 1993; 91:2693-702.
30. Res PC, Schaar CG, Breedveld FC, van Eden W, van Embden JD, Cohen IR, de Vries RR. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988; 2:478-80.
31. Tsoulfa G, Rook GA, Bahr GM et al. Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol 1989; 30:519-27.
32. Jones DB, Coulson AF, Duff GW. Sequence homologies between hsp60 and autoantigens. Immunol Today 1993; 14:115-8.
33. Kazuhiro M, Ohsawa M, Hu S, Kanno H, Aozasa K, Nose M. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Artheritis Rheum 1998; 41:369-73.
34. Kaufmann SH. Heat shock proteins and the immune response. Immunol Today 1990; 11:129-36.
35. Anderton SM, van der Zee R, Goodacre JA. Inflammation activates self hsp60-specific T cells. Eur J Immunol 1993; 23:33-8.
36. Weiss RA, Madaio MP, Tomaszewski JE, Kelly CJ. T cells reactive to an inducible heat shock protein induce disease in toxin-induced interstitial nephritis. J Exp Med 1994; 180:2239-50.
37. Ugrinovic S, Mertz A, Wu P, Braun J, Sieper J. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. Immunol 1997; 159:5715-23.
38. Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995; 96:2569-77.
39. Tripathy NK, Sinha N, Nityanand S. Anti-annexin-V antibodies in Takayasn's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003; 134:360-64.